Michael Buchert 34th Lorne Cancer Conference 2022

Abstracts this author is presenting:

• The kinase activity of the cancer stem cell marker DCLK1 orchestrates pro-tumorigenic stromal changes — Session 5: Difficult to Treat Cancers